首页> 美国卫生研究院文献>The Journal of Experimental Medicine >T cell suppressors of antitumor immunity. The production of Ly-1-2+ suppressors of delayed sensitivity precedes the production of suppressors of protective immunity published erratum appears in J Exp Med 1986 Dec 1;164(6):2131
【2h】

T cell suppressors of antitumor immunity. The production of Ly-1-2+ suppressors of delayed sensitivity precedes the production of suppressors of protective immunity published erratum appears in J Exp Med 1986 Dec 1;164(6):2131

机译:抗肿瘤免疫的T细胞抑制剂。延迟敏感性的Ly-1-2 +抑制剂的产生先于保护性免疫抑制剂的产生发表的勘误出现在J Exp Med 1986 Dec 1; 164(6):2131

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

The results of this study show that during growth of the immunogenic Meth A fibrosarcoma, two different types of suppressor T lymphocytes are generated in sequence. One type is generated during early tumor growth, reaches peak number around day 6, and is progressively lost thereafter. It is defined by its ability, upon passive transfer, to suppress the expression of a DTH reaction to tumor antigens in tumor- immunized recipients. It bears the Ly1-,2+ membrane phenotype and is sensitive to relatively low doses of cyclophosphamide. In contrast, the second type of suppressor cell is not detected until after day 9 of tumor growth, and is defined by its ability to inhibit, upon passive transfer, the expression of adoptive immunity against an established tumor in T cell-deficient recipients. According to previous studies it bears the Ly1+,2-, L3T4a+ membrane phenotype and is less sensitive to cyclophosphamide than the T cell suppressor of DTH. It is argued that this second type of suppressor T cell seems likely to be responsible for the escape of immunogenic tumors from antitumor immunity, because it can suppress the expression of a powerful mechanism of antitumor immunity in recipient mice, and is generated progressively as the tumor- bearing host loses concomitant immunity. In contrast, although the Ly-1- ,2+ T cell suppressors of DTH can efficiently suppress a DTH reaction to an implant of living tumor cells, they fail to suppress the expression of immunity to the same implant.
机译:这项研究的结果表明,在免疫原性Meth A纤维肉瘤的生长过程中,依次产生了两种不同类型的抑制性T淋巴细胞。一种类型在早期肿瘤生长期间产生,在第6天左右达到峰值,然后逐渐消失。通过其在被动转移时抑制DTH反应在肿瘤免疫受体中对肿瘤抗原表达的能力来定义。它具有Ly1-,2 +膜表型,并且对相对低剂量的环磷酰胺敏感。相比之下,直到肿瘤生长的第9天后才检测到第二种抑制细胞,并由其在被动转移时抑制T细胞缺陷受体中针对已建立肿瘤的过继免疫表达的能力来定义。根据以前的研究,它具有Ly1 +,2-,L3T4a +膜表型,并且对环磷酰胺的敏感性低于DTH的T细胞抑制剂。有人认为,第二种抑制性T细胞似乎可能是导致免疫原性肿瘤逃避抗肿瘤免疫的原因,因为它可以抑制受体小鼠抗肿瘤免疫的强大机制的表达,并随着肿瘤的产生而逐渐产生。 -宿主失去伴随的免疫力。相反,尽管DTH的Ly-1-,2 + T细胞抑制剂可以有效地抑制对活肿瘤细胞植入物的DTH反应,但是它们不能抑制对同一植入物的免疫表达。

著录项

相似文献

  • 外文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号